Genomic Valley Biotech Limited reported earnings results for the third quarter and nine months ended December 31, 2021. For the third quarter, the company reported sales was INR 0.24624 million compared to INR 0.91662 million a year ago. Revenue was INR 1.03 million compared to INR 0.91662 million a year ago. Net income was INR 0.108497 million compared to net loss of INR 0.136263 million a year ago. Basic earnings per share from continuing operations was INR 0.04 compared to basic loss per share from continuing operations of INR 0.04 a year ago. Diluted earnings per share from continuing operations was INR 0.04 compared to diluted loss per share from continuing operations of INR 0.04 a year ago.
For the nine months, sales was INR 0.70564 million compared to INR 1.86 million a year ago. Revenue was INR 1.49 million compared to INR 1.86 million a year ago. Net loss was INR 1.55 million compared to INR 1.75 million a year ago. Basic loss per share from continuing operations was INR 0.51 compared to INR 0.57 a year ago. Diluted loss per share from continuing operations was INR 0.51 compared to INR 0.57 a year ago.